Oncimmune Holdings (GB:ONC) has released an update.
Oncimmune Holdings PLC has reported a revenue increase to £1.19m in the first half of FY2024, up from £1.12m in the same period previous year, with a reduced operating loss of £0.76m compared to last year’s £3.53m. The company maintains its FY2024 revenue forecast, buoyed by new project contracts and a positive outlook with expected revenues of around £3m. Oncimmune’s strategic reset and commercial efforts appear to be gaining traction, with a rebuilt commercial team actively engaging in new commercial opportunities and collaborations.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
